We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
- Authors
Chlebowski, Rowan T; Col, Nananda; Winer, Eric P; Collyar, Deborah E; Cummings, Steven R; Vogel, Victor G, 3rd; Burstein, Harold J; Eisen, Andrea; Lipkus, Isaac; Pfister, David G; American Society of Clinical Oncology Breast Cancer Technology Assessment Working Group
- Abstract
To update an evidence-based technology assessment of chemoprevention strategies for breast cancer risk reduction. POTENTIAL INTERVENTIONS: Tamoxifen, raloxifene, aromatase inhibition, and fenretinide.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Vol 20, Issue 15, p3328
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2002.06.029